Investors generally don't turn to pharmaceutical stocks with expectations of high growth in a short period of time. Instead, they scoop up these players for their promise of steady gains over the ...

Eli Lilly's share price now stands above $1,000. The company's outlook through the next few years seems strong. The pharma giant looks likely to conduct a stock split in the (relatively) near future.

Eli Lilly stock has soared in the triple digits over three years. Investors are excited about the company’s portfolio of weight loss drugs, which has generated blockbuster revenue. 10 stocks we like ...

While stock splits don't strengthen a company's underlying business, corporations do them for several reasons. One is to keep the price of their shares within a "reasonable" window that makes it ...

But Eli Lilly (LLY 0.01%), in recent years, has offered investors the safety pharma stocks are known for and impressive growth. This is thanks to the company's leadership in the dynamic area of weight ...